Related references
Note: Only part of the references are listed.Blood-brain barrier transport using a high affinity, brain-selective VNAR antibody targeting transferrin receptor 1
Pawel Stocki et al.
FASEB JOURNAL (2021)
Structure-guided multivalent nanobodies block SARS-CoV-2 infection and suppress mutational escape
Paul-Albert Koenig et al.
SCIENCE (2021)
Proteomics reveals distinct mechanisms regulating the release of cytokines and alarmins during pyroptosis
Kshiti Phulphagar et al.
CELL REPORTS (2021)
A Probe for NLRP3 Inflammasome Inhibitor MCC950 Identifies Carbonic Anhydrase 2 as a Novel Target
Cassandra R. Kennedy et al.
ACS CHEMICAL BIOLOGY (2021)
Gasdermin E permits interleukin-1 beta release in distinct sublytic and pyroptotic phases
Bowen Zhou et al.
CELL REPORTS (2021)
Inflammasome-induced extracellular vesicles harbour distinct RNA signatures and alter bystander macrophage responses
Christina F. Budden et al.
JOURNAL OF EXTRACELLULAR VESICLES (2021)
Single domain antibody-based vectors in the delivery of biologics across the blood-brain barrier: a review
Yang Gao et al.
DRUG DELIVERY AND TRANSLATIONAL RESEARCH (2021)
Inflammasomes in the pathophysiology of autoinflammatory syndromes
Sarang Tartey et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2020)
Inflammasomes contributing to inflammation in arthritis
Lotte Spel et al.
IMMUNOLOGICAL REVIEWS (2020)
Engineered probiotics for local tumor delivery of checkpoint blockade nanobodies
Candice R. Gurbatri et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
IC100: a novel anti-ASC monoclonal antibody improves functional outcomes in an animal model of multiple sclerosis
Haritha L. Desu et al.
JOURNAL OF NEUROINFLAMMATION (2020)
β-Amyloid Clustering around ASC Fibrils Boosts Its Toxicity in Microglia
Lea L. Friker et al.
CELL REPORTS (2020)
Platelets Fuel the Inflammasome Activation of Innate Immune Cells
Verena Rolfes et al.
CELL REPORTS (2020)
Therapeutic modulation of inflammasome pathways
Dhruv Chauhan et al.
IMMUNOLOGICAL REVIEWS (2020)
Real-world data confirm the effectiveness of caplacizumab in acquired thrombotic thrombocytopenic purpura
Linus A. Voelker et al.
BLOOD ADVANCES (2020)
Human GBP1 binds LPS to initiate assembly of a caspase-4 activating platform on cytosolic bacteria
Jose Carlos Santos et al.
NATURE COMMUNICATIONS (2020)
Indirect regulation of HMGB1 release by gasdermin D
Allen Volchuk et al.
NATURE COMMUNICATIONS (2020)
Identification and in vivo characterization of a brain-penetrating nanobody
Y. Wouters et al.
FLUIDS AND BARRIERS OF THE CNS (2020)
Caspase-8-dependent gasdermin D cleavage promotes antimicrobial defense but confers susceptibility to TNF-induced lethality
Benjamin Demarco et al.
SCIENCE ADVANCES (2020)
Dapansutrile, an oral selective NLRP3 inflammasome inhibitor, for treatment of gout flares: an open-label, dose-adaptive, proof-of-concept, phase 2a trial
Viola Kluck et al.
LANCET RHEUMATOLOGY (2020)
Anti-interleukin-1 treatment in patients with rheumatoid arthritis and type 2 diabetes (TRACK): A multicentre, open-label, randomised controlled trial
Piero Ruscitti et al.
PLOS MEDICINE (2019)
Gout
Nicola Dalbeth et al.
NATURE REVIEWS DISEASE PRIMERS (2019)
Inflammasome Activation Induced by Perfringolysin O of Clostridium perfringens and Its Involvement in the Progression of Gas Gangrene
Kiyonobu Yamamura et al.
FRONTIERS IN MICROBIOLOGY (2019)
Caplacizumab Treatment for Acquired Thrombotic Thrombocytopenic Purpura
M. Scully et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Anakinra for the treatment of acute gout flares: a randomized, double-blind, placebo-controlled, active-comparator, non-inferiority trial
Carly A. Janssen et al.
RHEUMATOLOGY (2019)
Risk of Infections and Cancer in Patients With Rheumatologic Diseases Receiving Interleukin Inhibitors A Systematic Review and Meta-analysis
Jawad Bilal et al.
JAMA NETWORK OPEN (2019)
The intra- and extracellular functions of ASC specks
Bernardo S. Franklin et al.
IMMUNOLOGICAL REVIEWS (2018)
Mechanism of membrane pore formation by human gasdermin-D
Estefania Mulvihill et al.
EMBO JOURNAL (2018)
Targeting the NLRP3 inflammasome in inflammatory diseases
Matthew S. J. Mangan et al.
NATURE REVIEWS DRUG DISCOVERY (2018)
Assessment of ASC specks as a putative biomarker of pyroptosis in myelodysplastic syndromes: an observational cohort study
Ashley A. Basiorka et al.
LANCET HAEMATOLOGY (2018)
Pathogen blockade of TAK1 triggers caspase-8-dependent cleavage of gasdermin D and cell death
Pontus Orning et al.
SCIENCE (2018)
Evidence of inflammasome activation and formation of monocyte-derived ASC specks in HIV-1 positive patients
Fareed Ahmad et al.
AIDS (2018)
Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial
Paul M. Ridker et al.
LANCET (2017)
Microglia-derived ASC specks cross-seed amyloid-β in Alzheimer's disease
Carmen Venegas et al.
NATURE (2017)
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
P. M. Ridker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
In vivo imaging of inflammasome activation reveals a subcapsular macrophage burst response that mobilizes innate and adaptive immunity
Pervinder Sagoo et al.
NATURE MEDICINE (2016)
Half-life extended biotherapeutics
Roland E. Kontermann
EXPERT OPINION ON BIOLOGICAL THERAPY (2016)
A single domain antibody fragment that recognizes the adaptor ASC defines the role of ASC domains in inflammasome assembly
Florian I. Schmidt et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2016)
ASC filament formation serves as a signal amplification mechanism for inflammasomes
Mathias S. Dick et al.
NATURE COMMUNICATIONS (2016)
A Fluorescent Reporter Mouse for Inflammasome Assembly Demonstrates an Important Role for Cell-Bound and Free ASC Specks during In Vivo Infection
Te-Chen Tzeng et al.
CELL REPORTS (2016)
Phenotypic lentivirus screens to identify functional single domain antibodies
Florian I. Schmidt et al.
NATURE MICROBIOLOGY (2016)
The Inflammasomes and Autoinflammatory Syndromes
Lori Broderick et al.
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 10 (2015)
The PYRIN Domain-only Protein POP1 Inhibits Inflammasome Assembly and Ameliorates Inflammatory Disease
Lucia de Almeida et al.
IMMUNITY (2015)
A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases
Rebecca C. Coll et al.
NATURE MEDICINE (2015)
Joint production of IL-22 participates in the initial phase of antigen-induced arthritis through IL-1β production
Larissa G. Pinto et al.
ARTHRITIS RESEARCH & THERAPY (2015)
Intracellular Expression of Camelid Single-Domain Antibodies Specific for Influenza Virus Nucleoprotein Uncovers Distinct Features of Its Nuclear Localization
Joseph Ashour et al.
JOURNAL OF VIROLOGY (2015)
Prion-like Polymerization Underlies Signal Transduction in Antiviral Immune Defense and Inflammasome Activation
Xin Cai et al.
CELL (2014)
Unified Polymerization Mechanism for the Assembly of ASC-Dependent Inflammasomes
Alvin Lu et al.
CELL (2014)
The adaptor ASC exacerbates lethal Listeria monocytogenes infection by mediating IL-18 production in an inflammasome-dependent and -independent manner
Kohsuke Tsuchiya et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2014)
The NLRP3 inflammasome is released as a particulate danger signal that amplifies the inflammatory response
Alberto Baroja-Mazo et al.
NATURE IMMUNOLOGY (2014)
The adaptor ASC has extracellular and 'prionoid' activities that propagate inflammation
Bernardo S. Franklin et al.
NATURE IMMUNOLOGY (2014)
SMOCs: supramolecular organizing centres that control innate immunity
Jonathan C. Kagan et al.
NATURE REVIEWS IMMUNOLOGY (2014)
Efficacy of anakinra in gouty arthritis: a retrospective study of 40 cases
Sebastien Ottaviani et al.
ARTHRITIS RESEARCH & THERAPY (2013)
Central and overlapping role of Cathepsin B and inflammasome adaptor ASC in antigen presenting function of human dendritic cells
Xiuyang Guo et al.
HUMAN IMMUNOLOGY (2012)
Rapid induction of inflammatory lipid mediators by the inflammasome in vivo
Jakob von Moltke et al.
NATURE (2012)
Inflammasome-independent role of the apoptosis-associated speck-like protein containing CARD (ASC) in the adjuvant effect of MF59
Ali H. Ellebedy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals
Peter Duewell et al.
NATURE (2010)
IL-17 mediates articular hypernociception in antigen-induced arthritis in mice
Larissa G. Pinto et al.
PAIN (2010)
Risk of serious infections during rituximab, abatacept and anakinra treatments for rheumatoid arthritis: meta-analyses of randomised placebo-controlled trials
C. Salliot et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
A molecular platform in neurons regulates inflammation after spinal cord injury
Juan Pablo de Rivero Vaccari et al.
JOURNAL OF NEUROSCIENCE (2008)
Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization
Veit Hornung et al.
NATURE IMMUNOLOGY (2008)
The efficacy of anakinra in an adolescent with colchicine-resistant familial Mediterranean fever
Lorenzo Calligaris et al.
EUROPEAN JOURNAL OF PEDIATRICS (2008)
Effective treatment of a colchicine-resistant familial Mediterranean fever patient with anakinra
Loes M. Kuijk et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
The pyroptosome: a supramolecular assembly of ASC dimers mediating inflammatory cell death via caspase-1 activation
T. Fernandes-Alnemri et al.
CELL DEATH AND DIFFERENTIATION (2007)
Alpaca (Lama pacos) as a convenient source of recombinant camelid heavy chain antibodies (VHHs)
David R. Maass et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2007)
Gout-associated uric acid crystals activate the NALP3 inflammasome
F Martinon et al.
NATURE (2006)
Vertical collapse of a cytolysin prepore moves its transmembrane β-hairpins to the membrane
DM Czajkowsky et al.
EMBO JOURNAL (2004)
The inflammasome:: A molecular platform triggering activation of inflammatory caspases and processing of proIL-β
F Martinon et al.
MOLECULAR CELL (2002)
Share Paper
